Endometrial Cancer Associated with Defective DNA Mismatch Repair

Obstetrics and Gynecology Clinics of North America

Volumn 34, Issue 4, 2007, Pages 701-715

  Soliman, Pamela T ^a   Lu, Karen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MEDROXYPROGESTERONE ACETATE; MISMATCH REPAIR PROTEIN PMS2; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLON CANCER; COLORECTAL CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FAMILIAL CANCER; GENE AMPLIFICATION; GENE MUTATION; GENETIC DISORDER; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS CARCINOMA; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE CANCER; STOMACH CANCER; TRANSVAGINAL ECHOGRAPHY; URETER CANCER;

DNA MISMATCH REPAIR; DNA REPAIR; DNA REPLICATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 36549084621     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2007.09.003     Document Type: Review

References (42)

1. Black D., Soslow R.A., Levine D.A., et al. Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J Clin Oncol 24 11 (2006) 1745-1753
2. Vasen H.F., Mecklin J.P., Khan P.M., et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34 5 (1991) 424-425
3. Gurin C.C., Federici M.G., Kang L., et al. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res 59 2 (1999) 462-466
4. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 4 (2004) 261-268
5. Gryfe R., Kim H., Hsieh E.T., et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342 2 (2000) 69-77
6. Caduff R.F., Johnston C.M., Svoboda-Newman S.M., et al. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 148 5 (1996) 1671-1678
7. Fiumicino S., Ercoli A., Ferrandina G., et al. Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma. J Clin Oncol 19 4 (2001) 1008-1014
8. Maxwell G.L., Risinger J.I., Alvarez A.A., et al. Favorable survival associated with microsatellite instability in endometrioid endometrial cancers. Obstet Gynecol 97 3 (2001) 417-422
9. Wong Y.F., Ip T.Y., Chung T.K., et al. Clinical and pathologic significance of microsatellite instability in endometrial cancer. Int J Gynecol Cancer 9 5 (1999) 406-410
10. Tibiletti M.G., Furlan D., Taborelli M., et al. Microsatellite instability in endometrial cancer: relation to histological subtypes. Gynecol Oncol 73 2 (1999) 247-252
11. MacDonald N.D., Salvesen H.B., Ryan A., et al. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. Cancer Res 60 6 (2000) 1750-1752
12. Baldinu P., Cossu A., Manca A., et al. Microsatellite instability and mutation analysis of candidate genes in unselected Sardinian patients with endometrial carcinoma. Cancer 94 12 (2002) 3157-3168
13. Basil J.B., Goodfellow P.J., Rader J.S., et al. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer 89 8 (2000) 1758-1764
14. Catasus L., Machin P., Matias-Guiu X., et al. Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. Hum Pathol 29 10 (1998) 1160-1164
15. Zighelboim I., Goodfellow P.J., Gao F., et al. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. J Clin Oncol 25 15 (2007) 2042-2048
16. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81 2 (1999) 214-218
17. Dunlop M.G., Farrington S.M., Carothers A.D., et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6 1 (1997) 105-110
18. Vasen H.F., Stormorken A., Menko F.H., et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19 20 (2001) 4074-4080
19. Green J., O'Driscoll M., Barnes A., et al. Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation. Dis Colon Rectum 45 9 (2002) 1223-1232
20. Watson P., Vasen H.F., Mecklin J.P., et al. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 96 6 (1994) 516-520
21. Wijnen J., de Lecuw W., Vasen H., et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23 2 (1999) 142-144
22. Hendriks Y.M., Wagner A., Morreau H., et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127 1 (2004) 17-25
23. Lu K., Dinh M., Kohlmann W., et al. Gynecological malignancy as a "sentinel cancer" for women with HNPCC. Gynecol Oncol 92 (2004) 421
24. Lu K.H., Schorge J.O., Rodabaugh K.J., et al. Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. J Clin Oncol 25 33 (2007)
25. Millar A.L., Pal T., Madlensky L., et al. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum Mol Genet 8 5 (1999) 823-829
26. Soliman P.T., Slomovitz B.M., Broaddus R.R., et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 94 2 (2004) 456-462
27. Soliman P.T., Broaddus R.R., Schmeler K.M., et al. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?. J Clin Oncol 23 36 (2005) 9344-9350
28. Vasen H.F., Watson P., Mecklin J.P., et al. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. Anticancer Res 14 4B (1994) 1675-1678
29. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56 1 (2006) 11-25 quiz 49-50
30. National Comprehensive Cancer Network. Hereditary predisposition: HNPCC follow-up (surveillance). 2006.
31. Chung L., Broaddus R., Crozier M., et al. Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer. Obstet Gynecol 102 5 Pt 2 (2003) 1152-1155
32. Broaddus R.R., Lynch H.T., Chen L.M., et al. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer 106 1 (2006) 87-94
33. Boks D.E., Trujillo A.P., Voogd A.C., et al. Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int J Cancer 102 2 (2002) 198-200
34. Berends M.J., Hollema H., Wu Y., et al. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Int J Cancer 92 3 (2001) 398-403
35. Zhou X.P., Kuismanen S., Nystrom-Lahti M., et al. Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors. Hum Mol Genet 11 4 (2002) 445-450
36. Burke W., Petersen G., Lynch P., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 277 11 (1997) 915-919
37. Dove-Edwin I., Boks D., Goff S., et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 94 6 (2002) 1708-1712
38. Rijcken F.E., Mourits M.J., Kleibeuker J.H., et al. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 91 1 (2003) 74-80
39. Dijkhuizen F.P., Mol B.W., Brolmann H.A., et al. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 89 8 (2000) 1765-1772
40. Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. JAMA 257 6 (1987) 796-800
41. Schmeler K.M., Lynch H.T., Chen L.M., et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354 3 (2006) 261-269
42. Chen S., Wang W., Lee S., et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296 12 (2006) 1479-1487